Lafutidine


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 20.6%
Gastritis 13.2%
Osteoporosis 11.8%
Rheumatoid Arthritis 11.8%
Hyperlipidaemia 7.4%
Asthma 4.4%
Gastric Ulcer 4.4%
Cough 2.9%
Drug Use For Unknown Indication 2.9%
Otitis Media Chronic 2.9%
Polyuria 2.9%
Stent Placement 2.9%
Antifungal Prophylaxis 1.5%
Bile Duct Stone 1.5%
Constipation 1.5%
Diabetes Mellitus 1.5%
Hyperphosphaturia 1.5%
Hyperuricaemia 1.5%
Musculoskeletal Pain 1.5%
Rhinitis Allergic 1.5%
Liver Disorder 25.0%
Blood Creatinine Increased 8.3%
Cerebral Infarction 8.3%
Electrocardiogram Qt Prolonged 8.3%
Parkinsonism 8.3%
Vomiting 8.3%
Anaphylactic Shock 4.2%
Lymphocyte Stimulation Test Positive 4.2%
Musculoskeletal Discomfort 4.2%
Pruritus 4.2%
Pruritus Generalised 4.2%
Pulmonary Alveolar Haemorrhage 4.2%
Thrombotic Thrombocytopenic Purpura 4.2%
White Blood Cell Count Decreased 4.2%
Concomitant
Rheumatoid Arthritis 15.3%
Drug Use For Unknown Indication 13.5%
Product Used For Unknown Indication 11.4%
Hiv Infection 7.7%
Prophylaxis 7.0%
Back Pain 5.5%
Hypertension 5.4%
Sepsis 3.8%
Gastric Ulcer 3.2%
Urinary Tract Infection 3.0%
Hepatitis C 2.8%
Staphylococcal Infection 2.7%
Constipation 2.6%
Insomnia 2.6%
Prophylaxis Against Gastrointestinal Ulcer 2.5%
Cancer Pain 2.4%
Gastritis 2.3%
Diabetes Mellitus 2.1%
Hyperuricaemia 2.1%
Reflux Oesophagitis 2.1%
Breast Cancer 12.9%
Platelet Count Decreased 12.3%
White Blood Cell Count Decreased 12.3%
Hepatic Function Abnormal 5.8%
Pancytopenia 5.8%
Liver Disorder 5.2%
Sepsis 4.5%
Intestinal Obstruction 3.9%
Leukopenia 3.9%
Pneumonia 3.9%
Renal Impairment 3.9%
Staphylococcal Infection 3.9%
Interstitial Lung Disease 3.2%
Malaise 3.2%
Rash 3.2%
White Blood Cell Count Increased 3.2%
Nausea 2.6%
Vesical Fistula 2.6%
Alanine Aminotransferase Increased 1.9%
Bronchopneumonia 1.9%

Drug Data